SE311521B - - Google Patents

Info

Publication number
SE311521B
SE311521B SE14146/63A SE1414663A SE311521B SE 311521 B SE311521 B SE 311521B SE 14146/63 A SE14146/63 A SE 14146/63A SE 1414663 A SE1414663 A SE 1414663A SE 311521 B SE311521 B SE 311521B
Authority
SE
Sweden
Application number
SE14146/63A
Inventor
V Musil
B Brunova
O Nemecek
Z Horakova
Original Assignee
Spofa Vereinigte Pharma Werke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spofa Vereinigte Pharma Werke filed Critical Spofa Vereinigte Pharma Werke
Publication of SE311521B publication Critical patent/SE311521B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/28—Two oxygen or sulfur atoms
    • C07D231/30—Two oxygen or sulfur atoms attached in positions 3 and 5
    • C07D231/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/28—Two oxygen or sulfur atoms
    • C07D231/30—Two oxygen or sulfur atoms attached in positions 3 and 5
    • C07D231/32—Oxygen atoms
    • C07D231/36—Oxygen atoms with hydrocarbon radicals, substituted by hetero atoms, attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
SE14146/63A 1962-12-19 1963-12-18 SE311521B (OSRAM)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS712962 1962-12-19

Publications (1)

Publication Number Publication Date
SE311521B true SE311521B (OSRAM) 1969-06-16

Family

ID=5419846

Family Applications (1)

Application Number Title Priority Date Filing Date
SE14146/63A SE311521B (OSRAM) 1962-12-19 1963-12-18

Country Status (10)

Country Link
US (1) US3328418A (OSRAM)
AT (1) AT244956B (OSRAM)
BE (1) BE641454A (OSRAM)
BR (1) BR6355534D0 (OSRAM)
DE (1) DE1470260A1 (OSRAM)
DK (1) DK115333B (OSRAM)
FI (1) FI44405B (OSRAM)
GB (1) GB1054862A (OSRAM)
NL (2) NL302278A (OSRAM)
SE (1) SE311521B (OSRAM)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2773880A (en) * 1955-09-23 1956-12-11 Synfarma Narodni Podnik Process for producing 4-substituted 1, 2-diaryl-3, 5-dioxo pyrazolidines
US3123616A (en) * 1960-05-27 1964-03-03 C o nxe

Also Published As

Publication number Publication date
BE641454A (OSRAM)
US3328418A (en) 1967-06-27
GB1054862A (OSRAM)
BR6355534D0 (pt) 1973-07-17
NL129209C (OSRAM)
DK115333B (da) 1969-09-29
FI44405B (OSRAM) 1971-08-02
DE1470260A1 (de) 1969-04-10
NL302278A (OSRAM)
AT244956B (de) 1966-02-10

Similar Documents

Publication Publication Date Title
BE628237A (OSRAM)
BE627794A (OSRAM)
BE628721A (OSRAM)
BE620474A (OSRAM)
NL302278A (OSRAM)
BE630063A (OSRAM)
BE630005A (OSRAM)
BE620837A (OSRAM)
BE629735A (OSRAM)
BE627977A (OSRAM)
BE617118A (OSRAM)
BE621948A (OSRAM)
BE627650A (OSRAM)
BE626272A (OSRAM)
BE627049A (OSRAM)
BE624035A (OSRAM)
BE632887A (OSRAM)
BE629680A (OSRAM)
BE622049A (OSRAM)
BE627463A (OSRAM)
BE629700A (OSRAM)
BE630207A (OSRAM)
BE628131A (OSRAM)
BE630371A (OSRAM)
BE617735A (OSRAM)